DRTECH Corporation

KOSDAQ:A214680 Stock Report

Market Cap: ₩175.0b

DRTECH Past Earnings Performance

Past criteria checks 0/6

DRTECH's earnings have been declining at an average annual rate of -30.4%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 14.9% per year.

Key information

-30.4%

Earnings growth rate

-22.3%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate14.9%
Return on equity-24.0%
Net Margin-20.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

DRTECH Corporation's (KOSDAQ:214680) Popularity With Investors Is Under Threat From Overpricing

Oct 31
DRTECH Corporation's (KOSDAQ:214680) Popularity With Investors Is Under Threat From Overpricing

DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

Sep 11
DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

DRTECH Corporation's (KOSDAQ:214680) 28% Price Boost Is Out Of Tune With Revenues

Jul 17
DRTECH Corporation's (KOSDAQ:214680) 28% Price Boost Is Out Of Tune With Revenues

What DRTECH Corporation's (KOSDAQ:214680) 34% Share Price Gain Is Not Telling You

May 08
What DRTECH Corporation's (KOSDAQ:214680) 34% Share Price Gain Is Not Telling You

DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

Apr 29
DRTECH (KOSDAQ:214680) Is Carrying A Fair Bit Of Debt

We Think DRTECH (KOSDAQ:214680) Has A Fair Chunk Of Debt

Apr 14
We Think DRTECH (KOSDAQ:214680) Has A Fair Chunk Of Debt

Reflecting on DRTECH's (KOSDAQ:214680) Share Price Returns Over The Last Three Years

Feb 17
Reflecting on DRTECH's (KOSDAQ:214680) Share Price Returns Over The Last Three Years

DRTECH (KOSDAQ:214680) Is Making Moderate Use Of Debt

Dec 22
DRTECH (KOSDAQ:214680) Is Making Moderate Use Of Debt

Revenue & Expenses Breakdown

How DRTECH makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A214680 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2493,302-18,76328,63716,380
30 Jun 2489,823-13,90627,98513,179
31 Mar 2486,598-8,56728,36712,361
31 Dec 2392,439-2,24827,55111,517
30 Sep 2393,339-1,65427,28510,197
30 Jun 2394,1472,33226,9929,981
31 Mar 2394,4986,61223,89810,740
31 Dec 2289,4815,96421,88010,819
30 Sep 2281,4287,25521,55110,915
30 Jun 2275,6275,03018,99010,973
31 Mar 2273,0154,75019,96411,042
31 Dec 2170,2774,03817,97611,016
30 Sep 2169,76194817,56410,687
30 Jun 2164,884-2,07216,90810,295
31 Mar 2158,726-6,97315,0389,894
31 Dec 2055,268-7,23015,7539,236
30 Sep 2054,409-1,61113,7118,674
30 Jun 2052,574113,3448,304
31 Mar 2049,7211,28512,3477,688
31 Dec 1947,84594511,9937,171
30 Sep 1946,8671,19411,6947,064
30 Jun 1946,64182111,8476,831
31 Mar 1945,8301,20312,1986,316
31 Dec 1844,7141,24611,6946,131
30 Sep 1841,883-52311,0105,405
30 Jun 1839,816-1,53611,0865,301
31 Mar 1839,785-1,55411,2875,077
31 Dec 1738,804-1,81510,9335,378
30 Sep 1739,003-71710,4915,213
30 Jun 1737,232-1,76810,0975,349
31 Mar 1738,336-1009,2105,621
31 Dec 1636,639-4359,6894,808

Quality Earnings: A214680 is currently unprofitable.

Growing Profit Margin: A214680 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A214680 is unprofitable, and losses have increased over the past 5 years at a rate of 30.4% per year.

Accelerating Growth: Unable to compare A214680's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A214680 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-16.5%).

Return on Equity

High ROE: A214680 has a negative Return on Equity (-23.99%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 14:12
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DRTECH Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution